Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months:an observational multi-center study
- Publication date
- 1 January 2014
- Publisher
- 'Springer Science and Business Media LLC'